Potential of T-regulatory cells to protect xenografts

Purpose of reviewImmunological barriers still preclude clinical xenotransplantation. The protective role of CD4+CD25+Foxp3+ T-regulatory cells (Treg) in allotransplantation is well described and, therefore, could represent a promising therapeutical tool for xenotransplantation. This review addresses the latest findings on Treg in xenotransplantation research. Recent findingsIn vivo, costimulation blockade-based strategies including anti-CD154 monoclonal antibodies (mAbs) in combination with rapamycin or anti-LFA-1 mAb prolonged both concordant and discordant islets xenografts survival in a Treg-dependent manner. In vitro, IL-10 secretion was shown to be critical for the suppression of xenogeneic responses mediated by Treg. Moreover, transgenic expression of inducible costimulator-immunoglobulin or PD-L1 on porcine endothelial cells inhibited human T-cell proliferation in vitro and was associated with the induction of Treg and IL-10 secretion. CXCR3 mediated the recruitment of Treg to pig endothelium. Finally, the recruitment of human Treg was enhanced by the immobilization of human CCL17 on pig endothelium. SummaryThere is increasing evidence for the potential of CD4+CD25+Foxp3+ Treg to protect xenografts. Induction of Treg in recipients and/or recruitment of human Treg to pig endothelium may represent novel strategies to prevent cell-mediated rejection in pig-to-human xenotransplantation.

[1]  R. Bottino,et al.  Clinical xenotransplantation: the next medical revolution? , 2012, The Lancet.

[2]  K. Reimann,et al.  Nondepleting Anti‐CD40‐Based Therapy Prolongs Allograft Survival in Nonhuman Primates , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  A. Kirk,et al.  LFA-1 blockade induces effector and regulatory T-cell enrichment in lymph nodes and synergizes with CTLA-4Ig to inhibit effector function. , 2011, Blood.

[4]  V. Serre-Beinier,et al.  Immunosuppressive Effects of Streptozotocin-Induced Diabetes Result in Absolute Lymphopenia and a Relative Increase of T Regulatory Cells , 2011, Diabetes.

[5]  M. Levings,et al.  Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets. , 2011, The Journal of clinical investigation.

[6]  D. Irimia,et al.  Subsets of human CD4+ regulatory T cells express the peripheral homing receptor CXCR3 , 2011, European journal of immunology.

[7]  Liming Lu,et al.  Human PD‐L1‐overexpressing porcine vascular endothelial cells induce functionally suppressive human CD4+CD25hiFoxp3+ Treg cells , 2011, Journal of leukocyte biology.

[8]  F. Ierino,et al.  Prolonged Xenograft Survival Induced by Inducible Costimulator-Ig Is Associated With Increased Forkhead Box P3+ Cells , 2011, Transplantation.

[9]  S. Zheng,et al.  Generation of human regulatory T cells de novo with suppressive function prevent xenogeneic graft versus host disease. , 2011, International immunopharmacology.

[10]  G. Korbutt,et al.  CD40‐Specific Costimulation Blockade Enhances Neonatal Porcine Islet Survival in Nonhuman Primates , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[11]  R. Ueda,et al.  Immunopathogenesis of lymphoma: Focus on CCR4 , 2011, Cancer science.

[12]  Xiaomin Wang,et al.  Combination of antibodies inhibits accelerated rejection mediated by memory T cells in xenoantigen‐primed mice , 2010, Xenotransplantation.

[13]  J. Grotenhuis,et al.  Prognostic significance and mechanism of Treg infiltration in human brain tumors , 2010, Journal of Neuroimmunology.

[14]  S. Takao,et al.  CD4+ CD25+ regulatory T cells suppressed the indirect xenogeneic immune response mediated by porcine epithelial cell pulsed dendritic cells , 2010, Xenotransplantation.

[15]  Lei Sun,et al.  IL‐10 is required for human CD4+CD25+ regulatory T cell‐mediated suppression of xenogeneic proliferation , 2010, Immunology and cell biology.

[16]  Vasilis Toxavidis,et al.  In vivo tracking of 'color-coded' effector, natural and induced regulatory T cells in the allograft response , 2010, Nature Medicine.

[17]  P. Hart,et al.  Lentivirus‐mediated gene transfer of interleukin 10 to the ovine and human cornea , 2010, Clinical & experimental ophthalmology.

[18]  Song-Cheol Kim,et al.  Impact of Immunosuppressants on the Therapeutic Efficacy of In Vitro-Expanded CD4+CD25+Foxp3+ Regulatory T Cells in Allotransplantation , 2010, Transplantation.

[19]  V. Serre-Beinier,et al.  Anti-CD154 mAb and Rapamycin Induce T Regulatory Cell Mediated Tolerance in Rat-to-Mouse Islet Transplantation , 2010, PloS one.

[20]  A. Plege,et al.  Stimulatory and inhibitory receptor interactions in xenotransplantation , 2010, Current opinion in organ transplantation.

[21]  Lei Sun,et al.  Foxp3 regulates human natural CD4+CD25+ regulatory T‐cell‐mediated suppression of xenogeneic response , 2010, Xenotransplantation.

[22]  G. Korbutt,et al.  Short-Term Administrations of a Combination of Anti–LFA-1 and Anti-CD154 Monoclonal Antibodies Induce Tolerance to Neonatal Porcine Islet Xenografts in Mice , 2010, Diabetes.

[23]  Hélène Dumortier,et al.  CXCR3, Inflammation, and Autoimmune Diseases , 2009, Annals of the New York Academy of Sciences.

[24]  G. Blancho,et al.  Current cellular immunological hurdles in pig-to-primate xenotransplantation. , 2009, Transplant immunology.

[25]  L. Bühler,et al.  T regulatory cells in xenotransplantation , 2009, Xenotransplantation.

[26]  A. Plege,et al.  Suppression of Human T-Cell Activation and Expansion of Regulatory T Cells by Pig Cells Overexpressing PD-Ligands , 2009, Transplantation.

[27]  T. Berney,et al.  Long‐Term Insulin‐Independence After Allogeneic Islet Transplantation for Type 1 Diabetes: Over the 10‐Year Mark , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[28]  D. Umetsu,et al.  Decreases in circulating CD4+CD25hiFOXP3+ cells and increases in intragraft FOXP3+ cells accompany allograft rejection in pediatric liver allograft recipients , 2009, Pediatric transplantation.

[29]  P. Parrilla,et al.  FoxP3 in Peripheral Blood Is Associated With Operational Tolerance in Liver Transplant Patients During Immunosuppression Withdrawal , 2008, Transplantation.

[30]  R. Lechler,et al.  Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice. , 2008, The Journal of clinical investigation.

[31]  R. Lechler,et al.  The importance of the indirect pathway of allorecognition in clinical transplantation. , 2008, Current opinion in immunology.

[32]  I. Joosten,et al.  Clinical Grade Treg: GMP Isolation, Improvement of Purity by CD127pos Depletion, Treg Expansion, and Treg Cryopreservation , 2008, PloS one.

[33]  E. Bonifacio,et al.  Rapamycin Monotherapy in Patients With Type 1 Diabetes Modifies CD4+CD25+FOXP3+ Regulatory T-Cells , 2008, Diabetes.

[34]  C. Nguan,et al.  Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model. , 2008, Transplant immunology.

[35]  Mårten K. J. Schneider,et al.  Current cellular innate immune hurdles in pig-to-primate xenotransplantation , 2008, Current opinion in organ transplantation.

[36]  R. Negrin,et al.  Interleukin-2 receptor downstream events in regulatory T cells: Implications for the choice of immunosuppressive drug therapy , 2008, Cell cycle.

[37]  Wei Zhou,et al.  IL-10 Gene Modified Dendritic Cells Inhibit T Helper Type 1-Mediated Alloimmune Responses and Promote Immunological Tolerance in Diabetes , 2008, Cellular and Molecular Immunology.

[38]  C. Baan,et al.  Expression Patterns of Regulatory T‐Cell Markers in Accepted and Rejected Nonhuman Primate Kidney Allografts , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[39]  W. Weimar,et al.  Intragraft FOXP3 mRNA Expression Reflects Antidonor Immune Reactivity in Cardiac Allograft Patients , 2007, Transplantation.

[40]  R. Lechler,et al.  In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance. , 2007, Blood.

[41]  R. Lechler,et al.  From current immunosuppressive strategies to clinical tolerance of allografts , 2007, Transplant international : official journal of the European Society for Organ Transplantation.

[42]  E. Bonifacio,et al.  Induction of Tolerance in Type 1 Diabetes via Both CD4+CD25+ T Regulatory Cells and T Regulatory Type 1 Cells , 2006, Diabetes.

[43]  V. Sharma,et al.  Messenger RNA for FOXP3 in the urine of renal-allograft recipients. , 2005, The New England journal of medicine.

[44]  E. Bloom,et al.  Human CD4+CD25+ Regulatory T Cells Suppress Anti‐Porcine Xenogeneic Responses , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[45]  M. Dorf,et al.  Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor , 2005, The Journal of experimental medicine.

[46]  R. Lechler,et al.  Achieving permanent survival of islet xenografts by independent manipulation of direct and indirect T-cell responses. , 2005, Diabetes.

[47]  H. Auchincloss,et al.  Prolonged survival of fetal pig islet xenografts in mice lacking the capacity for an indirect response , 2004, Xenotransplantation.

[48]  Jeffrey A. Bluestone,et al.  In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes , 2004, The Journal of experimental medicine.

[49]  Narendra P. Singh,et al.  Blockade of indirect recognition mediated by CD4+ T cells leads to prolonged cardiac xenograft survival , 2004, Xenotransplantation.

[50]  G. Korbutt,et al.  The degree of phylogenetic disparity of islet grafts dictates the reliance on indirect CD4 T-cell antigen recognition for rejection. , 2003, Diabetes.

[51]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[52]  S. H. A. Chen,et al.  Production of α1,3-Galactosyltransferase-Deficient Pigs , 2002, Science.

[53]  R. Lechler,et al.  Costimulatory blockade by the induction of an endogenous xenospecific antibody response , 2000, Nature Immunology.

[54]  J. Fabre,et al.  The induction of major histocompatibility complex class II expression is sufficient for the direct activation of human CD4+ T cells by porcine vascular endothelial cells. , 2000, Transplantation.

[55]  T. Strom,et al.  Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance , 1999, Nature Medicine.

[56]  T. Strom,et al.  Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance , 1999, Nature Medicine.

[57]  R. Colvin,et al.  Human CD4+ T cells mediate rejection of porcine xenografts. , 1999, Journal of immunology.

[58]  R. Lechler,et al.  T cell‐mediated xenograft rejection: Specific tolerance is probably required for long term xenograft survival , 1998, Xenotransplantation.

[59]  H. Auchincloss,et al.  The strength of cell‐mediated xenograft rejection in the mouse is due to the CD4+ indirect response , 1998, Xenotransplantation.

[60]  D. Sachs,et al.  Species differences in the expression of major histocompatibility complex class II antigens on coronary artery endothelium: implications for cell-mediated xenoreactivity. , 1997, Transplantation.

[61]  J. Pober,et al.  Porcine aortic endothelial cells activate human T cells: direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. , 1994, Immunity.

[62]  L. Bühler,et al.  Transplantation tolerance: Clinical potential of regulatory T cells. , 2011, Self Nonself.

[63]  D. Long,et al.  Do CD4+ Foxp3+ Treg cells correlate with transplant outcomes: a systematic review on recipients of solid organ transplantation. , 2011, Cellular immunology.

[64]  M. Okabe,et al.  Complement regulation in the GalT KO era , 2010, Xenotransplantation.

[65]  Tinghua Cao,et al.  Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD). , 2009, Cellular immunology.

[66]  O. Joffre,et al.  Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes , 2008, Nature Medicine.

[67]  T. Starzl,et al.  Production of alpha 1,3-galactosyltransferase-deficient pigs. , 2003, Science.